Only two reports have shown that DJ-1 could promote EMT in breast cancer cells and human proximal tubular epithelial cells via repressing KLF17 expression or PTEN expression (Ismail et al., 2014; Yao et al., 2011). Here, KLF17 is linked to breast carcinoma.